23Andme Holding Co.: 23Me-00610 Monotherapy Demonstrates Preliminary Evidence of Clinical Benefit, Including One Confirmed Partial Response
23Andme Holding Co.:23Me-00610單藥療法展現初步臨床效益,包括一個確認的部分反應。
23Andme Holding Co.: 23Me-00610 Monotherapy Demonstrates Preliminary Evidence of Clinical Benefit, Including One Confirmed Partial Response
23Andme Holding Co.:23Me-00610單藥療法展現初步臨床效益,包括一個確認的部分反應。
譯文內容由第三人軟體翻譯。